US Patent 7704996 Compounds and compositions useful as cathepsin S inhibitors
Patent 7704996 was granted and assigned to Novartis on April, 2010 by the United States Patent and Trademark Office.
All edits
Edits on 30 Oct, 2023
Golden AI
Edits made to:
Article (+102 characters)
Article
Patent abstract
The present invention relates to the use of a 2-cyanopyrimidine compound of the formula
Edits on 18 Sep, 2023
Golden AI
Edits made to:
Infobox (+10 properties)
Infobox
Patent Inventor Names
Allan Hallett0
Atsuko Iwasaki0
Fumiaki Yokokawa0
Hajime Hirao0
Junichi Sakaki0
Keiichi Masuya0
Masashi Kishida0
Osamu Irie0
Takeru Ehara0
Terance William Hart0
Edits on 20 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07704996 Compounds and compositions useful as cathepsin S inhibitors US Patent 7704996 Compounds and compositions useful as cathepsin S inhibitors
Infobox
Patent Number
077049960
Patent Number
77049960
Edits on 19 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 23 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
077049960
Date of Patent
April 27, 2010
0Patent Application Number
115734510
Date Filed
August 16, 2005
0Official Website
Patent Primary Examiner
Edits on 18 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 4 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07704996 Compounds and compositions useful as cathepsin S inhibitors
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07704996
Date of patent
April 27, 2010
Patent application number
11573451
Date Filed
August 16, 2005
Patent primary examiner
Find more entities like US Patent 7704996 Compounds and compositions useful as cathepsin S inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
